IFF

    In vitro effects of essential oils on potential pathogens and beneficial members of the normal microbiota

    The use of antimicrobial growth promoters has been banned in the EU. This has created an interest in alternative strategies to prevent an imbalance in the intestinal microbiota and the potential development of intestinal disorders in livestock. Essential oils (EOs) have been known to exhibit antimicrobial activity against specific microbial species and could therefore be considered one such alternative in controlling the intestinal microbial population. Under anaerobic conditions, the tested Clostridium perfringens strains were found to be sensitive(P < 0.05) to carvacrol, cinnamaldehyde, citral, limonene, thymol, particularly at the higher concentration tested (500 mg/l) and to oregano oil, rosemary oil and thyme oil. Streptococcus epidermis was sensitive (P < 0.05) to most EO's tested, also mainly at the higher concentration. The tested Salmonella serovars were found to be sensitive (P <0.05) only to high (500 mg/l) concentrations of the tested EOs. Escherichia coli was sensitive (P < 0.05) to most of the tested EOs, also at lower concentrations (5 and 50 mg/l). Bifidobacterium longum, Bifidobacterium breve and Lactobacillus reuteri were less sensitive (P < 0.05) to most of the tested EOs, while Bifidobacterium animalis ssp. lactis and L. fermentum were relatively sensitive also at lower concentrations (5 and 50 mg/l), although growth reduction by EOs of these bacterial species was less then with the antimicrobial growth promoter avilamycin. With the exception of Salmonella and E. coli, all tested microbes were sensitive to avilamycin. Selected EOs seem to have the advantage of inhibiting the growth of potential pathogens while only moderately influencing beneficial members of the intestinal microbiota. This difference in sensitivity may strengthen the microbiota and contribute to improved animal health.
    Document information
    Product / service: Essential oils
    Publication date: 01/01/2010
    Species: Poultry, Broiler
    Authors: Ouwehand AC, Tiihonen K, Kettunen H, Peuranen S, Schulze H, Rautonen N
    Doctype: Publications & Citations
    Publication / conference: Veterinarni Medicina, volume 55, issue 2
    Regions and countries: Global
    Keywords: activity, anaerobic, animal, health, antimicrobial, growth, promoters, avilamycin, bacterial, bifidobacteria, bifidobacterium, animalis, longum, clostridia, clostridium, perfringens, coli, concentration, development, e, effects, escherichia, essential, oils, eu, promoter, in, vitro, in-vitro, intestinal, microbiota, l, lactobacillus, reuteri, livestock, microbes, microbial, population, oil, oregano, p, pathogens, salmonella, sensitivity, species, strain, streptococcus, thymol
    Production challenge(s): Gut health
    Diets: All diets
    Brands: Enviva® EO
    Resource ref: 11111
    This material is related to a conference
    Recently viewed

    Your single source for articles, publications & citations, product information and more...

    Much of the content on this site is freely available. Register now to receive email notifications based on your content preferences. Partners may also request access to the restricted area of the Knowledge Centre for technical product information such as trial data, reports and much more.

    Register for content notifications
    x

    DuPont's Nutrition & Biosciences and IFF are coming together

    This isn't about forming another industry giant. This is about merging curiosity and capability to create unique, leading-edge solutions at the intersection of science and creativity.

    To learn more about IFF and the merger, go to www.iff.com.